NeuroPace NPCE Stock
NeuroPace Price Chart
NeuroPace NPCE Financial and Trading Overview
| NeuroPace stock price | 13.5 USD |
| Previous Close | 4.2 USD |
| Open | 4.33 USD |
| Bid | 0 USD x 1100 |
| Ask | 0 USD x 1000 |
| Day's Range | 4.16 - 4.66 USD |
| 52 Week Range | 1.22 - 6.2 USD |
| Volume | 17.42K USD |
| Avg. Volume | 15.91K USD |
| Market Cap | 114.32M USD |
| Beta (5Y Monthly) | 2.542186 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.27 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.9 USD |
NPCE Valuation Measures
| Enterprise Value | 109.46M USD |
| Trailing P/E | N/A |
| Forward P/E | -2.7607362 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.351481 |
| Price/Book (mrq) | 4.1512914 |
| Enterprise Value/Revenue | 2.251 |
| Enterprise Value/EBITDA | -2.798 |
Trading Information
NeuroPace Stock Price History
| Beta (5Y Monthly) | 2.542186 |
| 52-Week Change | -10.53% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 6.2 USD |
| 52 Week Low | 1.22 USD |
| 50-Day Moving Average | 4.53 USD |
| 200-Day Moving Average | 3.51 USD |
NPCE Share Statistics
| Avg. Volume (3 month) | 15.91K USD |
| Avg. Daily Volume (10-Days) | 15.07K USD |
| Shares Outstanding | 25.41M |
| Float | 6.87M |
| Short Ratio | 33.28 |
| % Held by Insiders | 8.56% |
| % Held by Institutions | 86.10% |
| Shares Short | 463.99K |
| Short % of Float | 4.53% |
| Short % of Shares Outstanding | 1.83% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -94.60% |
| Operating Margin (ttm) | -80.93% |
| Gross Margin | 71.17% |
| EBITDA Margin | -80.45% |
Management Effectiveness
| Return on Assets (ttm) | -20.90% |
| Return on Equity (ttm) | -101.85% |
Income Statement
| Revenue (ttm) | 48.62M USD |
| Revenue Per Share (ttm) | 1.96 USD |
| Quarterly Revenue Growth (yoy) | 27.20% |
| Gross Profit (ttm) | 32.49M USD |
| EBITDA | -39116000 USD |
| Net Income Avi to Common (ttm) | -45996000 USD |
| Diluted EPS (ttm) | -1.82 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 67.62M USD |
| Total Cash Per Share (mrq) | 2.66 USD |
| Total Debt (mrq) | 70.37M USD |
| Total Debt/Equity (mrq) | 255.99 USD |
| Current Ratio (mrq) | 9.13 |
| Book Value Per Share (mrq) | 1.084 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -35174000 USD |
| Levered Free Cash Flow (ttm) | -22018376 USD |
Profile of NeuroPace
| Country | United States |
| State | CA |
| City | Mountain View |
| Address | 455 North Bernardo Avenue |
| ZIP | 94043 |
| Phone | 650 237 2700 |
| Website | https://www.neuropace.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 163 |
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. The company's RNS system also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip leads and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Q&A For NeuroPace Stock
What is a current NPCE stock price?
NeuroPace NPCE stock price today per share is 13.5 USD.
How to purchase NeuroPace stock?
You can buy NPCE shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for NeuroPace?
The stock symbol or ticker of NeuroPace is NPCE.
Which industry does the NeuroPace company belong to?
The NeuroPace industry is Medical Devices.
How many shares does NeuroPace have in circulation?
The max supply of NeuroPace shares is 28.34M.
What is NeuroPace Price to Earnings Ratio (PE Ratio)?
NeuroPace PE Ratio is now.
What was NeuroPace earnings per share over the trailing 12 months (TTM)?
NeuroPace EPS is -1.27 USD over the trailing 12 months.
Which sector does the NeuroPace company belong to?
The NeuroPace sector is Healthcare.
NeuroPace NPCE included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Market Composite NQGM | 2160.36 USD — |
-2.45
|
— — | 2147.48 USD — | 2200.33 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}